Phase 1, Single Dose Study to evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884

Trial Identifier:	D7870C00001
Sponsor:	MedImmune, LLC
NCTID::	NCT03001297
Start Date:	January 2017
Primary Completion Date:	August 2018
Study Completion Date:	August 2018
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	Japanese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, CA	Glendale, CA, United States of America, 91206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.